Transplant-Related Hematologic Malignancy

Transplant-Related Hematologic Malignancy — Trials · CancerIndex

Clinical trials

Registered studies

7 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Center for International Blood and Marrow Transplant Research
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07563010	Menin-Inhibitor Targeted Maintenance in AML	not yet recruiting	Phase 2	146	Center for International Blood and Marrow Transplant ResearchNETWORK	0	Jun 22, 2026	clinicaltrials

Data updated 22 days agoSource updated Jun 22, 2026source: clinicaltrials